Search

Your search keyword '"Kay, Neil E."' showing total 26 results
Start Over Author "Kay, Neil E." Journal american journal of hematology
26 results on '"Kay, Neil E."'

2. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis

Author

Muchtar, Eli, primary, Koehler, Amber B., additional, Johnson, Michael J., additional, Rabe, Kari G., additional, Ding, Wei, additional, Call, Timothy G., additional, Leis, Jose F., additional, Kenderian, Saad S., additional, Hayman, Suzanne R., additional, Wang, Yucai, additional, Hampel, Paul J., additional, Holets, Matthew A., additional, Darby, Heather C., additional, Slager, Susan L., additional, Kay, Neil E., additional, Miao, Congrong, additional, Canniff, Jennifer, additional, Whitaker, Jennifer A., additional, Levin, Myron J., additional, Schmid, D. Scott, additional, Kennedy, Richard B., additional, Weinberg, Adriana, additional, and Parikh, Sameer A., additional

Published
2021
Full Text
View/download PDF

4. The prognostic significance of del6q23 in chronic lymphocytic leukemia

Author

Audil, Hadiyah Y., primary, Hampel, Paul J., additional, Van Dyke, Daniel L., additional, Achenbach, Sara J., additional, Rabe, Kari G., additional, Smoley, Stephanie A., additional, Call, Timothy G., additional, Ding, Wei, additional, Shi, Min, additional, Hanson, Curtis A., additional, Wang, Yucai, additional, Muchtar, Eli, additional, Koehler, Amber B., additional, Schwager, Susan M., additional, Leis, Jose F., additional, Braggio, Esteban, additional, Slager, Susan L., additional, Kay, Neil E., additional, Kenderian, Saad S., additional, and Parikh, Sameer A., additional

Published
2021
Full Text
View/download PDF

5. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B‐cell lymphocytosis beyond theCLLinternational prognostic index

Author

Kleinstern, Geffen, primary, O'Brien, Daniel R., additional, Li, Xing, additional, Tian, Shulan, additional, Kabat, Brian F., additional, Rabe, Kari G., additional, Norman, Aaron D., additional, Yan, Huihuang, additional, Vachon, Celine M., additional, Boddicker, Nicholas J., additional, Call, Timothy G., additional, Parikh, Sameer A., additional, Bruins, Laura, additional, Bonolo de Campos, Cecilia, additional, Leis, Jose F., additional, Shanafelt, Tait D., additional, Ding, Wei, additional, Cerhan, James R., additional, Kay, Neil E., additional, Slager, Susan L., additional, and Braggio, Esteban, additional

Published
2020
Full Text
View/download PDF

6. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.

Author

Muchtar, Eli, Koehler, Amber B., Johnson, Michael J., Rabe, Kari G., Ding, Wei, Call, Timothy G., Leis, Jose F., Kenderian, Saad S., Hayman, Suzanne R., Wang, Yucai, Hampel, Paul J., Holets, Matthew A., Darby, Heather C., Slager, Susan L., Kay, Neil E., Miao, Congrong, Canniff, Jennifer, Whitaker, Jennifer A., Levin, Myron J., and Schmid, D. Scott

Published
2022
Full Text
View/download PDF

7. Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

Author

Hampel, Paul J., primary, Call, Timothy G., additional, Ding, Wei, additional, Muchtar, Eli, additional, Kenderian, Saad S., additional, Wang, Yucai, additional, Leis, Jose F., additional, Witzig, Thomas E., additional, Koehler, Amber B., additional, Fonder, Amie L., additional, Schwager, Susan M., additional, Rabe, Kari G., additional, Van Dyke, Daniel L., additional, Braggio, Esteban, additional, Slager, Susan L., additional, Kay, Neil E., additional, and Parikh, Sameer A., additional

Published
2019
Full Text
View/download PDF

8. IGHtranslocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

Author

Fang, Hong, primary, Reichard, Kaaren K., additional, Rabe, Kari G., additional, Hanson, Curtis A., additional, Call, Timothy G., additional, Ding, Wei, additional, Kenderian, Saad S., additional, Muchtar, Eli, additional, Schwager, Susan M., additional, Leis, Jose F., additional, Chanan-Khan, Asher A., additional, Slager, Susan L., additional, Braggio, Esteban, additional, Smoley, Stephanie A., additional, Kay, Neil E., additional, Shanafelt, Tait D., additional, Van Dyke, Daniel L., additional, and Parikh, Sameer A., additional

Published
2019
Full Text
View/download PDF

9. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B‐cell lymphocytosis beyond the CLL international prognostic index.

Author

Kleinstern, Geffen, O'Brien, Daniel R., Li, Xing, Tian, Shulan, Kabat, Brian F., Rabe, Kari G., Norman, Aaron D., Yan, Huihuang, Vachon, Celine M., Boddicker, Nicholas J., Call, Timothy G., Parikh, Sameer A., Bruins, Laura, Bonolo de Campos, Cecilia, Leis, Jose F., Shanafelt, Tait D., Ding, Wei, Cerhan, James R., Kay, Neil E., and Slager, Susan L.

Published
2020
Full Text
View/download PDF

10. Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

Author

Hampel, Paul J., Call, Timothy G., Ding, Wei, Muchtar, Eli, Kenderian, Saad S., Wang, Yucai, Leis, Jose F., Witzig, Thomas E., Koehler, Amber B., Fonder, Amie L., Schwager, Susan M., Rabe, Kari G., Van Dyke, Daniel L., Braggio, Esteban, Slager, Susan L., Kay, Neil E., and Parikh, Sameer A.

Published
2020
Full Text
View/download PDF

11. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients

Author

Molica, Stefano, Shanafelt, Tait D., Giannarelli, Diana, Gentile, Massimo, Mirabelli, Rosanna, Cutrona, Giovanna, Levato, Luciano, Di Renzo, Nicola, Di Raimondo, Francesco, Musolino, Caterina, Angrilli, Francesco, Famà, Angelo, Recchia, Anna Grazia, Chaffee, Kari G., Neri, Antonino, Kay, Neil E., Ferrarini, Manlio, and Morabito, Fortunato

Subjects
Adult, Male, leukemia, Hematology, Middle Aged, leukemia, Hematology, Prognosis, Leukemia, Lymphocytic, Chronic, B-Cell, Article, Time-to-Treatment, Cohort Studies, Italy, immune system diseases, Predictive Value of Tests, hemic and lymphatic diseases, Humans, Female, Prospective Studies, neoplasms, Aged
Abstract

The chronic lymphocytic leukemia International Prognostic Index (CLL-IPI) combines 5 parameters (age, clinical stage, TP53 status [normal vs. del(17p) and/or TP53 mutation], IGHV mutational status, serum β2-microglobulin) to predict survival and time-to-first-treatment (TTFT) in CLL patients. We performed an observational study in 337 prospectively collected, Binet stage A patients to validate the ability of the CLL-IPI to predict TTFT in an independent cohort of early stage CLL patients. The CLL-IPI score stratified Binet stage A patients into three subgroups with different outcome. Since the CLL-IPI was originally developed to predict survival, we next investigated the optimal cut-off score to predict TTFT in Binet stage A patients. Recursive partitioning analysis identified three subsets with scores of 0 (n = 139), 1 (n = 90), and ≥ 2(n = 108). The probability of remaining free from therapy 5 years after diagnosis was 85%, 67% and 46% in these three categories (P 0.0001.; C-statistic:c = 0.72; 95% CI:0.58-0.81). This optimized CLL-IPI scoring for TTFT was subsequently validated in an independent cohort of Binet A patients from the Mayo Clinic (n = 525). The ability of either original or optimized CLL-IPI to predict TTFT was equivalent to other prognostic models specifically designed for this endpoint (2011 MDACC score and O-CLL1 score). Although originally developed to predict suvival, the CLL-IPI is useful for predicting TTFT in early stage CLL patients. Am. J. Hematol. 91:1090-1095, 2016. © 2016 Wiley Periodicals, Inc.

Published
2016

12. Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings

Author

Hampel, Paul J., primary, Chaffee, Kari G., additional, King, Rebecca L., additional, Simonetto, Douglas, additional, Larson, Melissa C., additional, Achenbach, Sara, additional, Call, Timothy G., additional, Ding, Wei, additional, Kenderian, Saad S., additional, Leis, Jose F., additional, Chanan-Khan, Asher A., additional, Bowen, Deborah A., additional, Conte, Michael J., additional, Schwager, Susan M., additional, Hanson, Curtis A., additional, Slager, Susan L., additional, Kay, Neil E., additional, Shanafelt, Tait D., additional, and Parikh, Sameer A., additional

Published
2017
Full Text
View/download PDF

13. High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia

Author

Ravindran, Aishwarya, primary, Sankaran, Janani, additional, Jacob, Eapen K., additional, Kreuter, Justin D., additional, Hook, C. Christopher, additional, Gertz, Morie A., additional, Call, Timothy G., additional, Pruthi, Rajiv K., additional, Litzow, Mark R., additional, Wolanskyj, Alexandra P., additional, Hogan, William J., additional, Ashrani, Aneel A., additional, Begna, Kebede H., additional, Marshall, Ariela L., additional, Kyle, Robert A., additional, Kay, Neil E., additional, and Go, Ronald S., additional

Published
2017
Full Text
View/download PDF

14. Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

Author

Larsen, Jeremy T., primary, Shanafelt, Tait D., additional, Leis, Jose F., additional, LaPlant, Betsy, additional, Call, Tim, additional, Pettinger, Adam, additional, Hanson, Curtis, additional, Erlichman, Charles, additional, Habermann, Thomas Matthew, additional, Reeder, Craig, additional, Nikcevich, Daniel, additional, Bowen, Deborah, additional, Conte, Michael, additional, Boysen, Justin, additional, Secreto, Charla, additional, Lesnick, Connie, additional, Tschumper, Renee, additional, Jelinek, Diane, additional, Kay, Neil E., additional, and Ding, Wei, additional

Published
2017
Full Text
View/download PDF

17. Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study

Author

Friedman, Daphne R., primary, Sibley, Alexander B., additional, Owzar, Kouros, additional, Chaffee, Kari G., additional, Slager, Susan, additional, Kay, Neil E., additional, Hanson, Curtis A., additional, Ding, Wei, additional, Shanafelt, Tait D., additional, Weinberg, J. Brice, additional, and Wilcox, Ryan A., additional

Published
2016
Full Text
View/download PDF

18. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison tode novoHodgkin lymphoma

Author

Parikh, Sameer A., primary, Habermann, Thomas M., additional, Chaffee, Kari G., additional, Call, Timothy G., additional, Ding, Wei, additional, Leis, Jose F., additional, Macon, William R., additional, Schwager, Susan M., additional, Ristow, Kay M., additional, Porrata, Luis F., additional, Kay, Neil E., additional, Slager, Susan L., additional, and Shanafelt, Tait D., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results